Medtech company Imricor (ASX: IMR) has been awarded a contract from the US National Institutes of Health (NIH) to advance their leading MRI technology into a prototype device that can biopsy the inner walls of the heart. The awarded contract will see Imricor receive USD $399,539 over the next 12 months for the project where
Read More
We recently had a one-on-one meeting with Richard Tegoni (Chairman) at SECOS Group Ltd (SES). Given we do not cover the stock, the main purpose of this call was to get an initial understanding of the Company’s business model as we develop our knowledge on the stock. SES is a developer and manufacturer of sustainable
Read More
Security tech company Scout Security (ASX: SCT) could play a role in improvement of gun control in the United States, with their intruder alert technology set integrated into Amazon’s new smart home service Alexa Guard Plus under a revenue-sharing agreement. The Scout Alarm technology is specifically integrated into Amazon Echo devices with Amazon’s new Guard
Read More
It is finally back to business as planned for Gage Roads Brewing (ASX: GRB) which today can open the doors of its first venue, Atomic Beer Project, after its original opening date was pushed back six months due to the COVID-19 pandemic. Located in Redfern, New South Wales, Atomic Beer Project is the first hospitality
Read More
Biotech company CardieX (ASX: CDX) has expanded on an existing partnership with Chinese tech giant Mobvoi, which is backed by Google, for the launch of a new health-focused smartwatch which will incorporate CardieX’s software and artificial intelligence. The smartwatch will be developed in collaboration with Mobvoi to supply hardware and firmware with CardieX to then
Read More
It may soon be easier for prostate cancer to be diagnosed at an early stage with Telix Pharmaceuticals (ASX: TLX) having submitted their radiopharmaceutical imaging technology to the Food and Drug Administration for approval. The New Drug Application (NDA) comes after completing clinical trials across more than 600 patients which builds on peer-reviewed clinical research
Read More
